AQR Capital Management
PAVM icon

AQR Capital Management’s PAVmed PAVM Stock Holding History

AQR Capital Management’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-78
Closed -$87K – 2271
2021
Q4 		$87K Hold
78
– – ﹤0.01% 2161
2021
Q3 		$301K Hold
78
– – ﹤0.01% 2035
2021
Q2 		$226K Hold
78
– – ﹤0.01% 2118
2021
Q1 		$157K Sell
78
-107
-58% -$161K ﹤0.01% 2135
2020
Q4 		$176K Hold
185
– – ﹤0.01% 2105
2020
Q3 		$148K Buy
+185
New +$165K ﹤0.01% 2104

Other funds holding PAVM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Capital Management's PAVM Position: Q1 2022 in Review

AQR Capital Management sold out of PAVmed (PAVM) in Q1 2022, closing a stake of 78 shares — an estimated $87K sold.

AQR Capital Management first reported a position in PAVM in Q3 2020 and held it in 6 quarters. The position peaked at $301K in Q3 2021. 94 funds tracked by Wall St. Rank hold PAVM as of Q1 2022.

  • AQR Capital Management reported no remaining PAVmed position as of Q1 2022 after selling out during the quarter.
  • AQR Capital Management sold 78 PAVmed shares in Q1 2022, an estimated $87K.
  • AQR Capital Management first reported a position in PAVmed in Q3 2020 and held it in 6 quarters.
  • AQR Capital Management's PAVmed position peaked at $301K in Q3 2021.
  • 94 funds tracked by Wall St. Rank held PAVmed as of Q1 2022.

Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.